
Complex zzso exist between the zzso growth factor zzso zzso and vascular zzso growth factor zzso zzso zzso zzso zzso elicits cell proliferation and increased zzso zzso To zzso inhibit zzso and then downstream zzso activity, this phase I study was initiated to determine the maximum tolerated dose zzso of zzso with zzso zzso and then combine with zzso in patients with advanced zzso 

Patients with advanced zzso likely to express zzso were treated with a full dose of zzso intravenous weekly, combined with various doses of oral zzso daily zzso zzso Once the zzso was determined in Part 1, escalating doses of zzso were administered zzso biweekly zzso zzso 

Forty patients were enrolled and received 155 courses over four dose zzso In Part 1, zzso grade 3 rash occurred in two patients administered with zzso at 100 zzso daily, and the zzso of zzso for this combination was 50 zzso daily with zzso zzso (11 patients zzso Other adverse events included zzso zzso fatigue, and zzso In Part 2, zzso at 10 zzso intravenous every 2 weeks was safely added, with additional zzso headache, zzso and zzso There was one partial response in a patient with zzso cell zzso zzso stable disease was observed in five patients for zzso zzso 

The zzso for Part 1 was 50 zzso daily of zzso combined with standard zzso zzso at 10 zzso biweekly can be safely administered with the zzso for zzso and zzso zzso 

